{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:01:49Z","timestamp":1780992109247,"version":"3.54.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":144,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.idcr.2026.e02629","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:40:45Z","timestamp":1779781245000},"page":"e02629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Case report: Maribavir as salvage therapy for multidrug-resistant CMV DNAemia in a non-transplant patient with ocular cicatricial pemphigoid"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1122-1357","authenticated-orcid":false,"given":"Balachandran R.","family":"Vaidyanathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshaya","family":"Balaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2026.e02629_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/eye.2011.175","article-title":"Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid","author":"Williams","year":"2011","journal-title":"Eye"},{"key":"10.1016\/j.idcr.2026.e02629_bib2","article-title":"Anti-cytomegalovirus therapy: whether and when to initiate","author":"Aoyama","year":"2022","journal-title":"J Dermatol"},{"key":"10.1016\/j.idcr.2026.e02629_bib3","series-title":"Infect Dis Clin North Am","article-title":"Antiviral drug resistance: mechanisms and clinical implications","author":"Strasfeld","year":"2010"},{"key":"10.1016\/j.idcr.2026.e02629_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/QCO.0b013e32834cfb58","article-title":"The biology of cytomegalovirus drug resistance","author":"Hakki","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02629_bib5","article-title":"Maribavir for refractory cytomegalovirus infections: phase 3 results","author":"Avery","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02629_bib6","article-title":"Efficacy and safety of maribavir as a rescue treatment","author":"Pereira","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02629_bib7","article-title":"Real-world experience with maribavir for treatment of refractory CMV","author":"Daher","year":"2025","journal-title":"Transpl Cell Ther"},{"key":"10.1016\/j.idcr.2026.e02629_bib8","article-title":"Maribavir for multidrug-resistant CMV in an immunocompromised host","author":"Zarowin","year":"2024","journal-title":"IDCases"},{"key":"10.1016\/j.idcr.2026.e02629_bib9","article-title":"Consensus definitions of CMV infection and disease: 2024 update","author":"Ljungman","year":"2024","journal-title":"Transpl Assoc Virus Infect Forum"},{"key":"10.1016\/j.idcr.2026.e02629_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11785","article-title":"New treatment options for refractory\/resistant CMV infection","author":"Walti","year":"2023","journal-title":"Transpl Int"},{"key":"10.1016\/j.idcr.2026.e02629_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiab029","article-title":"Novel C480F Maribavir-Ganciclovir cross-resistance mutation","author":"Santos Bravo","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02629_bib12","series-title":"Transplantation","article-title":"New Insights on CMV Management in SOT Patients","author":"Kotton","year":"2022"},{"key":"10.1016\/j.idcr.2026.e02629_bib13","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/TP.0000000000005374","article-title":"The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation","author":"Kotton","year":"2025","journal-title":"Transplantation"},{"key":"10.1016\/j.idcr.2026.e02629_bib14","doi-asserted-by":"crossref","unstructured":"Kamar N., et al. CMV viremia clearance and post-solid organ transplant mortality. Am J Transplant. 2025).","DOI":"10.3389\/ti.2025.15331"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02629_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00043-19","article-title":"Progress and challenges in the prevention, diagnosis, and management of cytomegalovirus infection in transplantation","volume":"34","author":"Limaye","year":"2021","journal-title":"Clin Microbiol Rev"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926001423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926001423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:49:02Z","timestamp":1780991342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250926001423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":15,"alternative-id":["S2214250926001423"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02629","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Case report: Maribavir as salvage therapy for multidrug-resistant CMV DNAemia in a non-transplant patient with ocular cicatricial pemphigoid","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02629","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02629"}}